Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Refractory Seizures in TSC
NCT03356769Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2017
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in tuberous sclerosis complex (TSC), epilepsy, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
aspirin
03
Conditions
tuberous sclerosis complex (TSC)epilepsy
Beyond the preview
Go deeper on NCT03356769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356769.